Biological Agents and Psoriatic Epidermis: What Are We Ultimately Targeting?

Publisher： Karger

E-ISSN： 1421-9832|212|4|321-323

ISSN： 1018-8665

Source： Dermatology, Vol.212, Iss.4, 2006-05, pp. : 321-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Impact of Salt Water Soaks on Biophysical and Molecular Parameters in Psoriatic Epidermis Equivalents

By  

Dermatology, Vol. 223, Iss. 3, 2011-11 ,pp. : 230-238

Karger

Access to resources Recommend Favorite

Alteration and Significance of Heparin-Binding Epidermal-Growth-Factor-Like Growth Factor in Psoriatic Epidermis

By  

Dermatology, Vol. 207, Iss. 1, 2003-07 ,pp. : 22-27

Karger

Access to resources Recommend Favorite

Eosinophilic Fasciitis 30 Years after – What Do We Really Know?

By  

Dermatology, Vol. 213, Iss. 2, 2006-08 ,pp. : 93-101

Karger

Access to resources Recommend Favorite

What Can We Learn from Animal Models of Alopecia areata?

By  

Dermatology, Vol. 211, Iss. 1, 2005-07 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

By  

Dermatology, Vol. 225, Iss. 4, 2012-12 ,pp. : 312-319

Karger

Access to resources Recommend Favorite